Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arsenault

Showing results (221-230 of 282) with videos related to

Pageof 29
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 12, 2020
Thinning or dehiscence of bone in structures of the middle cranial fossa floor in superior semicircular canal dehiscenceJohn J Arsenault, Prasanth Romiyo, Tyler Miao, et al.
JAMA Network Open|February 29, 2020
Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization AnalysisBenoit J Arsenault, William Pelletier, Yannick Kaiser, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Cardiovascular Research|May 5, 2017
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathwayMohamed Jalloul Nsaibia, Marie-Chloé Boulanger, Rihab Bouchareb, et al.
Atherosclerosis|March 21, 2017
Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trialRomain Capoulade, Kwan L Chan, Patrick Mathieu, et al.
Obesity Surgery|July 16, 2020
Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe ObesityAudrey-Anne Després, Marie-Eve Piché, Audrey Auclair, et al.
Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Quebec's Multi-Party Observatory on Zoonoses and Adaptation to Climate ChangeG Germain, A Simon, J Arsenault, et al.
Plos One|December 23, 2014
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
Pageof 29

Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 12, 2020
Thinning or dehiscence of bone in structures of the middle cranial fossa floor in superior semicircular canal dehiscenceJohn J Arsenault, Prasanth Romiyo, Tyler Miao, et al.
JAMA Network Open|February 29, 2020
Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization AnalysisBenoit J Arsenault, William Pelletier, Yannick Kaiser, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Cardiovascular Research|May 5, 2017
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathwayMohamed Jalloul Nsaibia, Marie-Chloé Boulanger, Rihab Bouchareb, et al.
Atherosclerosis|March 21, 2017
Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trialRomain Capoulade, Kwan L Chan, Patrick Mathieu, et al.
Obesity Surgery|July 16, 2020
Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe ObesityAudrey-Anne Després, Marie-Eve Piché, Audrey Auclair, et al.
Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Quebec's Multi-Party Observatory on Zoonoses and Adaptation to Climate ChangeG Germain, A Simon, J Arsenault, et al.
Plos One|December 23, 2014
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkersBenoit J Arsenault, Philip Barter, David A DeMicco, et al.
Pageof 29